Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2018

Dec 6, 2018

33899_dirs_2018-12-06_8e4023d9-1c16-4a34-b518-1f2e562ffe5c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2018-12-03

Reporting Person: HALLQUIST CONSTANCE J. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-03 Common Stock S 1343 $153.84 Disposed 4687 Direct

Footnotes

F1: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.5529 to $154.2500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.